Afreen Shariff/LinkedIn
Jun 4, 2025, 12:25
Afreen Shariff: Checkpoint NOW Medical Podcast Series Delivered in Collaboration with ASPIRE
Afreen Shariff, Associate Director for the Cancer Therapy Toxicity Program at the Duke Center for Cancer Immunotherapy, shared a post on LinkedIn:
“Check out our updated website for celebrated Checkpoint NOW medical podcast series delivered in collaboration with ASPIRE- An American Society of Clinical Oncology (ASCO) Community of Practice.
It is surreal to see the growth since I started this in 2020 with a simple mission to make high-quality education available to patients, physicians and providers managing immune mediated toxicities irrespective of where they live.
Access free content right at your fingertips with all you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.
5 years
30 + episodes
1000s of downloads
listeners from 50+ countries
Mission-high-quality expert delivered education for patients and care teams.
Tune in today to learn more.”
Afreen Shariff shared the continued success of the Checkpoint NOW podcast series, which offers free, expert-led education on immune-related toxicities from cancer therapies. Launched in collaboration with ASCO’s ASPIRE community, the podcast has reached global audiences since 2020.
More posts featuring Afreen Shariff.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 16:33
Jun 4, 2025, 16:33
Jun 4, 2025, 15:56
Jun 4, 2025, 14:21
Jun 4, 2025, 13:42